Abstract Type 2 diabetes (T2D) is one of the most prevalent metabolic diseases worldwide
and is characterized by increased postprandial hyperglycemia (PPHG). α-Amylase and α …

Type 2 diabetes mellitus is a progressive disease that is characterized by the appearance of
insulin resistance. The term insulin resistance is very wide and could affect different proteins …

Although type 1 diabetes is traditionally considered a disease of lean people, overweight
and obesity are becoming increasingly more common in individuals with type 1 diabetes …

As a chronic metabolic disease, diabetes mellitus (DM) creates a hyperglycemic micromilieu
around implants, resulting inthe high complication and failure rate of implantation because …

Diabetes mellitus (DM) is an ensemble of metabolic conditions that have reached pandemic
proportions worldwide. Pathology's multifactorial nature makes patient management …

Type 2 diabetes mellitus (T2DM), accounting for 90–95% cases of diabetes, is characterized
by chronic inflammation. The mechanisms that control inflammation activation in T2DM are …

During the progression of type 1 diabetes (T1D), β cells are exposed to significant stress
and, therefore, require adaptive responses to survive. The adaptive mechanisms that can …

Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we
assess whether human β cell dysfunction induced by metabolic stress is reversible, evaluate …

Developing a miniaturized, low-cost, and smart closed-loop system for diabetes could
significantly improve life quality and benefit millions of people. Conventional closed-loop …

The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress
markers indicative of increased unfolded protein response (UPR) signaling is no longer in …